Stroke Feature Archive
The ultimate goal of stroke assessment is to enable physicians to make treatment decisions that are individualized and appropriate to the patient's needs, thereby improving patient outcomes.
For more details about differences in stroke risk, prevention, and treatment in women, Neurology Advisor spoke with Elisabeth B. Marsh, MD, from Johns Hopkins School of Medicine and Kristy Yuan, MD, from the University of Pennsylvania.
Brief periods of oxygen deprivation to the brain have been shown to provide neuroprotective effects that reduce stroke infarct size and improve recovery times.
Despite disappointing results, tenecteplase's story in stroke treatment might not be over.
Neurologists need to engage their emergency medicine colleagues to identify protocols and pathways for when to trigger appropriate neurological consultation or initiate acute stroke therapies.
Recent research found benefits in outcome outweighed any increase in hemorrhagic complications in patients with large infarcts.
Although the study did not demonstrate efficacy of glyburide, differences were seen in the amount midline shift at 3-4 days.
Despite 3 large randomized trials and updated guidelines, the question of PFO closure remains a complex entity.
A joint medical and surgical approach may ensure the best outcome.
The idea of low-dose tPA will likely not be abandoned despite recent findings.
Ticagrelor may have an opportunity to shine in patients already on aspirin or clopidogrel.
Patients undergoing cardiac surgery should be evaluated for cardiovascular disease to assess stroke risk.
Interventional stroke treatment continues to rapidly evolve as health care providers implement new protocols to ensure more rapid, successful treatment.
New recommendations for the treatment of acute stroke put emergency physicians and neurology stroke specialists at odds.
Overlapping clinical characteristics between women with migraine and those using contraceptives may indicate an elevated risk of stroke.
The affect of stroke on young adults goes far beyond functional disabilities.
With no established guidelines, much of the decisions for management of hypertension during stroke are based on clinician experience.
The long-awaited results of the MR CLEAN trial are sure to affect the future of acute stroke treatment.
Robotics, stem cell therapy, and computer-controlled interfaces are promising, but cost may slow adoption.
If the UTHealth mobile stroke unit program can show that treating ischemic stroke within 60 minutes is feasible and cost effective, more may start rolling out nationally.
Neurology Advisor Articles
- Survival in Parkinson Disease Dependent on Parkinsonian Type, Characteristics
- Case Study Report: Herbal Supplement Kratom Associated With Neonatal Abstinence Syndrome
- Mobile Health Apps for Headache: An Ongoing Search for Clinical Relevancy
- CBD Superior to Placebo, Similar to AEDs for Managing Epilepsy Syndromes
- Young Fresh Frozen Plasma Infusion Safe, Feasible in Alzheimer Disease
- Alemtuzumab Linked to Clinical and MRI Disease Remission in Multiple Sclerosis
- Very Early Mobilization After Stroke Does Not Improve Survival Over Usual Care
- Cognitive Decline Worsens With Memantine, ChEIs in Patients With Alzheimer's
- Cervical Dysfunction Needs Clarification to Identify Link With Headache
- Levodopa Inhalation Powder Approved for Parkinson Disease
- Can Early Initiation of Direct Oral Anticoagulants Prevent Recurrent AFib-Related Stroke?
- Hydrocephalus May Be a Complication of Congenial Zika Syndrome
- Higher CSF NfL Protein Levels Linked to Risk for Mild Cognitive Impairment
- Addressing Cognitive Impairment in Pediatric MS: Expert Q&A
- How the Government Shutdown Affects FDA Activities